Literature DB >> 16297770

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Susan Stewart1, Gayle L Winters, Michael C Fishbein, Henry D Tazelaar, Jon Kobashigawa, Jacki Abrams, Claus B Andersen, Annalisa Angelini, Gerald J Berry, Margaret M Burke, Anthony J Demetris, Elizabeth Hammond, Silviu Itescu, Charles C Marboe, Bruce McManus, Elaine F Reed, Nancy L Reinsmoen, E Rene Rodriguez, Alan G Rose, Marlene Rose, Nicole Suciu-Focia, Adriana Zeevi, Margaret E Billingham.   

Abstract

In 1990, an international grading system for cardiac allograft biopsies was adopted by the International Society for Heart Transplantation. This system has served the heart transplant community well, facilitating communication between transplant centers, especially with regard to patient management and research. In 2004, under the direction of the International Society for Heart and Lung Transplantation (ISHLT), a multidisciplinary review of the cardiac biopsy grading system was undertaken to address challenges and inconsistencies in its use and to address recent advances in the knowledge of antibody-mediated rejection. This article summarizes the revised consensus classification for cardiac allograft rejection. In brief, the revised (R) categories of cellular rejection are as follows: Grade 0 R--no rejection (no change from 1990); Grade 1 R--mild rejection (1990 Grades 1A, 1B and 2); Grade 2 R--moderate rejection (1990 Grade 3A); and Grade 3 R--severe rejection (1990 Grades 3B and 4). Because the histologic sub-types of Quilty A and Quilty B have never been shown to have clinical significance, the "A" and "B" designations have been eliminated. Recommendations are also made for the histologic recognition and immunohistologic investigation of acute antibody-mediated rejection (AMR) with the expectation that greater standardization of the assessment of this controversial entity will clarify its clinical significance. Technical considerations in biopsy processing are also addressed. This consensus revision of the Working Formulation was approved by the ISHLT Board of Directors in December 2004.

Entities:  

Mesh:

Year:  2005        PMID: 16297770     DOI: 10.1016/j.healun.2005.03.019

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  362 in total

1.  Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients.

Authors:  Violette Gijsen; Seema Mital; Ron H van Schaik; Offie P Soldin; Steven J Soldin; Ilse P van der Heiden; Irena Nulman; Gideon Koren; Saskia N de Wildt
Journal:  J Heart Lung Transplant       Date:  2011-09-17       Impact factor: 10.247

Review 2.  B cells in cardiac transplants: from clinical questions to experimental models.

Authors:  William M Baldwin; Marc K Halushka; Anna Valujskikh; Robert L Fairchild
Journal:  Semin Immunol       Date:  2011-09-19       Impact factor: 11.130

3.  Autoimmune sensitization to cardiac myosin leads to acute rejection of cardiac allografts in miniature swine.

Authors:  Gregory R Veillette; Hisashi Sahara; Andrew J Meltzer; Mathew J Weiss; Yoshiko Iwamoto; Karen M Kim; Bruce R Rosengard; James S Allan; Stuart L Houser; David H Sachs; Gilles Benichou; Joren C Madsen
Journal:  Transplantation       Date:  2011-06-15       Impact factor: 4.939

4.  New issues in heart transplantation for heart failure.

Authors:  Michelle M Kittleson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

5.  Plasmacytoma-like post-transplantation lymphoproliferative disease occurring in a cardiac allograft: a case report and review of the literature.

Authors:  Tzu-Fei Wang; Jonathan L Klein; Pamela K Woodard; Anjum Hassan; Susan M Joseph; Gregory A Ewald; Geoffrey L Uy
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

6.  Raman spectroscopy detects cardiac allograft rejection with molecular specificity.

Authors:  Yoon Gi Chung; Qiang Tu; Dianjun Cao; Shuko Harada; Howard J Eisen; Chang Chang
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

7.  Lymphatic injury and regeneration in cardiac allografts.

Authors:  Thing Rinda Soong; Arvind P Pathak; Hiroshi Asano; Karen Fox-Talbot; William M Baldwin
Journal:  Transplantation       Date:  2010-03-15       Impact factor: 4.939

8.  Physiological levels of reactive oxygen species are required to maintain genomic stability in stem cells.

Authors:  Tao-Sheng Li; Eduardo Marbán
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

9.  Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization.

Authors:  Nina Pilat; Benedikt Mahr; Lukas Unger; Karin Hock; Christoph Schwarz; Andreas M Farkas; Ulrike Baranyi; Fritz Wrba; Thomas Wekerle
Journal:  JCI Insight       Date:  2016-05-19

10.  Magnetic resonance imaging investigation of macrophages in acute cardiac allograft rejection after heart transplantation.

Authors:  Yijen L Wu; Qing Ye; Danielle F Eytan; Li Liu; Bedda L Rosario; T Kevin Hitchens; Fang-Cheng Yeh; Nico Rooijen van; Chien Ho
Journal:  Circ Cardiovasc Imaging       Date:  2013-10-04       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.